Azitra (AZTR) Shares Outstanding (Weighted Average) (2022 - 2026)

Azitra (AZTR) reported Shares Outstanding (Weighted Average) of $100000.0 for Q1 2026, down 94.94% on a YoY basis from $2.0 million in Q1 2025, and down 97.95% quarter-over-quarter from $4.9 million in Q4 2025.

Azitra (AZTR) Shares Outstanding (Weighted Average) (2022 - 2026) Analysis & Trends

Azitra has reported Shares Outstanding (Weighted Average) for 5 years, with the latest figure at $100000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) fell 94.94% year-over-year to $100000.0; the trailing twelve-month figure through Mar 2026 stood at $100000.0 (down 94.94% YoY), and the FY2025 full-year result was $4.9 million, up 28.78% from the prior year.
  • Shares Outstanding (Weighted Average) for Q1 2026 stood at $100000.0, down from $4.9 million in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $20.2 million in Q1 2024, with the low at $71622.0 in Q2 2023.
  • Historically, Shares Outstanding (Weighted Average) has averaged $3.5 million across 5 years, with a median of $1.1 million in 2022.
  • Annual changes were most pronounced in 2024 — Shares Outstanding (Weighted Average) surged 3266.66% — and 2026, when it plunged 94.94%.
  • Azitra's Shares Outstanding (Weighted Average) stood at $1.1 million in 2022, then plunged by 78.22% to $229866.0 in 2023, then surged by 148.48% to $571162.0 in 2024, then soared by 753.27% to $4.9 million in 2025, then tumbled by 97.95% to $100000.0 in 2026.
  • The last three Shares Outstanding (Weighted Average) figures came in at $100000.0 (Q1 2026), $4.9 million (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 185,491.37 Bn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 400.00 Bn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4,489.46 Bn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 100.00 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 417.01 Bn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 118.76 Bn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 68.88 Bn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 254.10 Mn
9 Abivax 91.96 Bn 91.96 Bn - 928.40 Mn
10 Azitra 20,900.00 20,900.00 - 100,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 100,000.00
Dec 31, 2025 4.87 Mn
Sep 30, 2025 2.00 Mn
Jun 30, 2025 14.73 Mn
Mar 31, 2025 1.98 Mn
Dec 31, 2024 571,162.00
Sep 30, 2024 5.81 Mn
Jun 30, 2024 960,146.00
Mar 31, 2024 20.18 Mn
Dec 31, 2023 229,866.00
Sep 30, 2023 172,704.00
Jun 30, 2023 71,622.00
Mar 31, 2023 1.06 Mn
Dec 31, 2022 1.06 Mn
Sep 30, 2022 1.06 Mn
Jun 30, 2022 1.06 Mn